Certain New Chemicals or Significant New Uses; Statements of Findings for June 2021, 46240-46242 [2021-17661]
Download as PDF
<![CDATA[
46240
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
to the following schedule. Revisions to
the schedule will be made as
appropriate.
Milestone
Target date
Deadline for filing interventions, protests, comments, recommendations, preliminary terms and conditions, and preliminary
fishway prescriptions.
Deadline for filing reply comments ..............................................................................................................................................
November 2021.
q. Final amendments to the
application must be filed with the
Commission no later than 30 days from
the issuance date of this notice.
Dated: August 12, 2021.
Kimberly D. Bose,
Secretary.
I. General Information
[FR Doc. 2021–17698 Filed 8–17–21; 8:45 am]
Dated: August 12, 2021.
Kimberly D. Bose,
Secretary.
BILLING CODE 6717–01–P
This action is directed to the public
in general. As such, the Agency has not
attempted to describe the specific
entities that this action may apply to.
Although others may be affected, this
action applies directly to the submitters
of the PMNs addressed in this action.
[FR Doc. 2021–17697 Filed 8–17–21; 8:45 am]
[EPA–HQ–OPPT–2021–0146; FRL–8682–03–
OCSPP]
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
Certain New Chemicals or Significant
New Uses; Statements of Findings for
June 2021
[Docket No. AD21–8–00]
Technical Conference on
Reassessment of the Electric Quarterly
Report Requirements; Notice of
Technical Conference
AGENCY:
Take notice that on October 14, 2021,
the Federal Energy Regulatory
Commission (Commission) will convene
a staff-led technical conference via
webcast as part of a reassessment of the
Electric Quarterly Report (EQR)
requirements. A supplemental notice
will be issued prior to the conference
with further details regarding the
agenda, meeting registration
information, and electronic log-in
information.
The purpose of this technical
conference is to provide a forum for
Commission staff, filers, and data users
to discuss potential changes to the
current EQR data fields. This technical
conference is the third in a series of
conferences related to a reassessment of
the EQR requirements.
Commission conferences are
accessible under section 508 of the
Rehabilitation Act of 1973. For
accessibility accommodations, please
send an email to accessibility@ferc.gov
or call toll free 1–866–208–3372 (voice)
or 202–502–8659 (TTY), or send a FAX
to 202–208–2106 with the required
accommodations.
For more information about the EQR
technical conference, please contact Jeff
Sanders of the Commission’s Office of
Enforcement at (202) 502–6455, or send
an email to EQR@ferc.gov. Additional
information will also be provided on the
EQR web page.
SUMMARY:
VerDate Sep<11>2014
17:34 Aug 17, 2021
A. Does this action apply to me?
ENVIRONMENTAL PROTECTION
AGENCY
BILLING CODE 6717–01–P
jbell on DSKJLSW7X2PROD with NOTICES
October 2021.
Jkt 253001
Environmental Protection
Agency (EPA).
ACTION:
Notice.
The Toxic Substances Control
Act (TSCA) requires EPA to publish in
the Federal Register a statement of its
findings after its review of certain TSCA
notices when EPA makes a finding that
a new chemical substance or significant
new use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to premanufacture notices (PMNs),
microbial commercial activity notices
(MCANs), and significant new use
notices (SNUNs) submitted to EPA
under TSCA. This document presents
statements of findings made by EPA on
such submissions during the period
from June 1, 2021 to June 30, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Rebecca Edelstein, New Chemicals
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: 202–564–1667;
email address: Edelstein.rebecca@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
B. How can I get copies of this document
and other related information?
The docket for this action, identified
by docket identification (ID) number
EPA–HQ–OPPT–2021–0146, is available
at https://www.regulations.gov or at the
Office of Pollution Prevention and
Toxics Docket (OPPT Docket),
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPPT
Docket is (202) 566–0280.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of
findings made by EPA after review of
notices submitted under TSCA section
5(a) that certain new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment. This document presents
statements of findings made by EPA
during the period from June 1, 2021 to
June 30, 2021.
III. What is the Agency’s authority for
taking this action?
TSCA section 5(a)(3) requires EPA to
review a TSCA section 5(a) notice and
E:\FR\FM\18AUN1.SGM
18AUN1
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
make one of the following specific
findings:
• The chemical substance or
significant new use presents an
unreasonable risk of injury to health or
the environment;
• The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects of the chemical
substance or significant new use;
• The information available to EPA is
insufficient to permit a reasoned
evaluation of the health and
environmental effects and the chemical
substance or significant new use may
present an unreasonable risk of injury to
health or the environment;
• The chemical substance is or will
be produced in substantial quantities,
and such substance either enters or may
reasonably be anticipated to enter the
environment in substantial quantities or
there is or may be significant or
substantial human exposure to the
substance; or
• The chemical substance or
significant new use is not likely to
present an unreasonable risk of injury to
health or the environment.
Unreasonable risk findings must be
made without consideration of costs or
other non-risk factors, including an
unreasonable risk to a potentially
EPA is required under TSCA section
5(g) to publish in the Federal Register
a statement of its findings after its
review of a TSCA section 5(a) notice
when EPA makes a finding that a new
chemical substance or significant new
use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to PMNs, MCANs, and SNUNs
submitted to EPA under TSCA section
5.
Anyone who plans to manufacture
(which includes import) a new chemical
substance for a non-exempt commercial
purpose and any manufacturer or
processor wishing to engage in a use of
a chemical substance designated by EPA
as a significant new use must submit a
notice to EPA at least 90 days before
commencing manufacture of the new
chemical substance or before engaging
in the significant new use.
The submitter of a notice to EPA for
which EPA has made a finding of ‘‘not
likely to present an unreasonable risk of
injury to health or the environment’’
may commence manufacture of the
chemical substance or manufacture or
processing for the significant new use
notwithstanding any remaining portion
of the applicable review period.
IV. Statements of Administrator
Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the
following information (to the extent that
such information is not claimed as
Confidential Business Information
(CBI)) on the PMNs, MCANs and
SNUNs for which, during this period,
EPA has made findings under TSCA
section 5(a)(3)(C) that the new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment:
• EPA case number assigned to the
TSCA section 5(a) notice.
• Chemical identity (generic name if
the specific name is claimed as CBI).
• Website link to EPA’s decision
document describing the basis of the
‘‘not likely to present an unreasonable
risk’’ finding made by EPA under TSCA
section 5(a)(3)(C).
EPA case No.
Chemical identity
Website link
J–21–0012 .............................
Yeast that has been stably modified for the production
of an agricultural product (generic).
Yeast that has been stably modified for the production
of an agricultural product (generic).
Carbonmonocyclic alkene polymer with alkyl alkenoate,
alkyl alkenoate, alkyl alkenoate and polyalkyldiene
alkenoate. (generic).
Phenol, polymer with alkyl-(alkylalkylenyl)cyclohexene,
mixed dialkylcyclohexadienes, mixed alkyl(alkylalkylidene)cyclohexenes and 3,7,7trimethylbicyclo[4.1.0]hept-3-ene (generic).
Alkene Homopolymer Hydrogenated (generic) ..............
https://www.epa.gov/system/files/documents/2021-07/j21-0012_determination_non-cbi_final_1.pdf.
https://www.epa.gov/system/files/documents/2021-07/j21-0013_determination_non-cbi_final.pdf.
https://www.epa.gov/system/files/documents/2021-08/p21-0005_determination_non-cbi_final_2.pdf.
J–21–0013 .............................
P–21–0005 ............................
P–21–0078 ............................
P–21–0095 ............................
P–21–0039, P–21–0040, P–
21–0041.
P–21–0103 ............................
(P–21–0039) 1,2,4,5-Benzenetetracarboxamide,
N1,N2,N4,N5-tetrahexyl-; CASRN: 1142038–73–0,
(P–21–0040) 1,2,4,5-Benzenetetracarboxamide,
N1,N2,N4,N5-tetraoctyl-; CASRN: 1416081–40–7,
(P–21–0041) 1,2,4,5-Benzenetetracarboxamide,
N1,N2,N4,N5-tetradodecyl-; CASRN: 911127–84–9.
Urea, N-[3-[[(4-methylphenyl)sulfonyl]oxy]phenyl]-N′phenyl-include; CASRN 2102522–55–2.
Authority: 15 U.S.C. 2601 et seq.
jbell on DSKJLSW7X2PROD with NOTICES
exposed or susceptible subpopulation
identified as relevant under the
conditions of use. The term ‘‘conditions
of use’’ is defined in TSCA section 3 to
mean ‘‘the circumstances, as determined
by the Administrator, under which a
chemical substance is intended, known,
or reasonably foreseen to be
manufactured, processed, distributed in
commerce, used, or disposed of.’’
46241
https://www.epa.gov/system/files/documents/2021-07/p21-0078_determination_non-cbi_final_0.pdf.
https://www.epa.gov/system/files/documents/2021-07/p21-0095_determination_non-cbi_final_0.pdf.
https://www.epa.gov/system/files/documents/2021-07/p21-0039-0041_determination_non-cbi_final.pdf.
https://www.epa.gov/system/files/documents/2021-07/p21-0103_determination_non-cbi_final.pdf.
Dated: August 10, 2021.
Madison Le,
Director, New Chemical Division, Office of
Pollution Prevention and Toxics.
[FR Doc. 2021–17661 Filed 8–17–21; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
18:17 Aug 17, 2021
Jkt 253001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\18AUN1.SGM
18AUN1
46242
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–SFUND–2005–0008; FRL–8827–
01–OLEM]
Proposed Information Collection
Request; Comment Request:
Emergency Planning and Release
Notification Requirements (EPCRA
Sections 302, 303, and 304), EPA ICR
Number 1395.11, OMB Control Number
2050–0092
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency is planning to submit an
information collection request (ICR),
‘‘Emergency Planning and Release
Notification Requirements,’’ (EPA ICR
No. 1395.11, OMB Control No. 2050–
0092) to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act. Before doing so, EPA is
soliciting public comments on specific
aspects of the proposed information
collection as described in
SUPPLEMENTARY INFORMATION. This is a
proposed extension of the ICR, which is
currently approved through April 30,
2022. An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
DATES: Comments must be submitted on
or before October 18, 2021.
ADDRESSES: Submit your comments,
referencing Docket ID No. EPA–HQ–
SFUND–2005–0008, to (1) EPA online
using www.regulations.gov (our
preferred method), by email to
superfund.docket@epa.gov or by mail
to: EPA Docket Center, Environmental
Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW,
Washington, DC 20460, and (2) OMB via
email to oira_submission@omb.eop.gov.
Address comments to OMB Desk Officer
for EPA.
EPA’s policy is that all comments
received will be included in the public
docket without change including any
personal information provided, unless
the comment includes profanity, threats,
information claimed to be Confidential
Business Information (CBI) or other
information whose disclosure is
restricted by statute.
FOR FURTHER INFORMATION CONTACT:
Wendy Hoffman, Office of Emergency
Management, Mail Code 5104A,
Environmental Protection Agency, 1200
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:17 Aug 17, 2021
Jkt 253001
Pennsylvania Ave. NW, Washington, DC
20460; telephone number: (202) 564–
8794; email address: hoffman.wendy@
epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents which explain in
detail the information that EPA will be
collecting are available in the public
docket for this ICR. The docket can be
viewed online at https://
www.regulations.gov. Out of an
abundance of caution for members of
the public and our staff, the EPA Docket
Center and Reading Room is closed to
the public, with limited exceptions, to
reduce the risk of transmitting COVID–
19. Our Docket Center staff will
continue to provide remote customer
service via email, phone, and webform.
For further information about the EPA’s
public docket, Docket Center services
and the current status, please visit us
online at https://www.epa.gov/dockets.
The telephone number for the Docket
Center is 202–566–1744.
Pursuant to section 3506(c)(2)(A) of
the PRA, EPA is soliciting comments
and information to enable it to: (i)
Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Agency, including
whether the information will have
practical utility; (ii) evaluate the
accuracy of the Agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(iii) enhance the quality, utility, and
clarity of the information to be
collected; and (iv) minimize the burden
of the collection of information on those
who are to respond, including through
the use of appropriate automated
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses. EPA will consider the
comments received and amend the ICR
as appropriate. The final ICR package
will then be submitted to OMB for
review and approval. At that time, EPA
will issue another Federal Register
notice to announce the submission of
the ICR to OMB and the opportunity to
submit additional comments to OMB.
Abstract: The authority for the
emergency planning and emergency
release notification requirements is
sections 302, 303, and 304 of the
Emergency Planning and Community
Right-to-Know Act (EPCRA) of 1986 (42
U.S.C. 11002, 11003, and 11004).
EPCRA established broad emergency
planning and facility reporting
requirements. Section 302 requires
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
facilities to notify their State Emergency
Response Commission (SERC) or Tribal
Emergency Response Commission
(TERC), Local Emergency Planning
Committee (LEPC) or Tribal Emergency
Planning Committee (TEPC) with
jurisdiction over their facility, of the
presence of a threshold planning
quantity of a listed extremely hazardous
substance (EHS) at the facility. This
activity was completed by existing
facilities soon after the law was passed.
Only new facilities that may become
subject to these requirements must
notify the SERC (or TERC) and the LEPC
(or TEPC). Currently covered facilities
are required to notify the LEPC (or
TEPC) of any changes that occur at the
facility which would be relevant to
emergency planning. Section 303
requires the LEPC (or TEPC) to prepare
local emergency response plans for their
planning district using the information
provided by facilities under Section
302. An LEPC (or TEPC) may request
any information from facilities
necessary to develop emergency
response plans. Initial emergency
response plans were developed within a
few months after the law was passed.
LEPCs (or TEPCs) are required to review
and update the plan at least annually or
more frequently as changes occur in the
community. Section 304 requires
facilities to report to SERCs (or TERCs)
and LEPCs (or TEPCs) releases in excess
of the reportable quantities listed for
each EHS. This ICR also covers the
notification and the written follow-up
required under Section 304. The
implementing regulations are codified
in 40 CFR part 355.
Form Numbers: None.
Respondents/affected entities: Entities
potentially affected by this action are
those which have a threshold planning
quantity of an EHS listed in 40 CFR part
355, Appendix A and those which have
a release of any of the EHSs above a
reportable quantity. Entities more likely
to be affected by this action may include
chemical manufacturers, retailers,
petroleum refineries, utilities, etc.
Respondent’s obligation to respond:
Mandatory (Sections 302, 303 and 304
of EPCRA).
Estimated number of respondents:
108,556. This figure includes 3,556
LEPCs (or TEPCs) and SERCs (or TERCs)
and will be updated, as needed, during
the 60-day OMB review period.
Frequency of response: EPCRA
section 302 reporting is a one-time
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 86, Number 157 (Wednesday, August 18, 2021)]
[Notices]
[Pages 46240-46242]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17661]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2021-0146; FRL-8682-03-OCSPP]
Certain New Chemicals or Significant New Uses; Statements of
Findings for June 2021
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to
publish in the Federal Register a statement of its findings after its
review of certain TSCA notices when EPA makes a finding that a new
chemical substance or significant new use is not likely to present an
unreasonable risk of injury to health or the environment. Such
statements apply to premanufacture notices (PMNs), microbial commercial
activity notices (MCANs), and significant new use notices (SNUNs)
submitted to EPA under TSCA. This document presents statements of
findings made by EPA on such submissions during the period from June 1,
2021 to June 30, 2021.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Rebecca Edelstein, New Chemicals
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: 202-564-1667; email address:
[email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. As such, the
Agency has not attempted to describe the specific entities that this
action may apply to. Although others may be affected, this action
applies directly to the submitters of the PMNs addressed in this
action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPPT-2021-0146, is available at https://www.regulations.gov or at the Office of Pollution Prevention and Toxics
Docket (OPPT Docket), Environmental Protection Agency Docket Center
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
II. What action is the Agency taking?
This document lists the statements of findings made by EPA after
review of notices submitted under TSCA section 5(a) that certain new
chemical substances or significant new uses are not likely to present
an unreasonable risk of injury to health or the environment. This
document presents statements of findings made by EPA during the period
from June 1, 2021 to June 30, 2021.
III. What is the Agency's authority for taking this action?
TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a)
notice and
[[Page 46241]]
make one of the following specific findings:
The chemical substance or significant new use presents an
unreasonable risk of injury to health or the environment;
The information available to EPA is insufficient to permit
a reasoned evaluation of the health and environmental effects of the
chemical substance or significant new use;
The information available to EPA is insufficient to permit
a reasoned evaluation of the health and environmental effects and the
chemical substance or significant new use may present an unreasonable
risk of injury to health or the environment;
The chemical substance is or will be produced in
substantial quantities, and such substance either enters or may
reasonably be anticipated to enter the environment in substantial
quantities or there is or may be significant or substantial human
exposure to the substance; or
The chemical substance or significant new use is not
likely to present an unreasonable risk of injury to health or the
environment.
Unreasonable risk findings must be made without consideration of
costs or other non-risk factors, including an unreasonable risk to a
potentially exposed or susceptible subpopulation identified as relevant
under the conditions of use. The term ``conditions of use'' is defined
in TSCA section 3 to mean ``the circumstances, as determined by the
Administrator, under which a chemical substance is intended, known, or
reasonably foreseen to be manufactured, processed, distributed in
commerce, used, or disposed of.''
EPA is required under TSCA section 5(g) to publish in the Federal
Register a statement of its findings after its review of a TSCA section
5(a) notice when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to PMNs,
MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture (which includes import) a new
chemical substance for a non-exempt commercial purpose and any
manufacturer or processor wishing to engage in a use of a chemical
substance designated by EPA as a significant new use must submit a
notice to EPA at least 90 days before commencing manufacture of the new
chemical substance or before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding
of ``not likely to present an unreasonable risk of injury to health or
the environment'' may commence manufacture of the chemical substance or
manufacture or processing for the significant new use notwithstanding
any remaining portion of the applicable review period.
IV. Statements of Administrator Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the following information (to the extent
that such information is not claimed as Confidential Business
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this
period, EPA has made findings under TSCA section 5(a)(3)(C) that the
new chemical substances or significant new uses are not likely to
present an unreasonable risk of injury to health or the environment:
EPA case number assigned to the TSCA section 5(a) notice.
Chemical identity (generic name if the specific name is
claimed as CBI).
Website link to EPA's decision document describing the
basis of the ``not likely to present an unreasonable risk'' finding
made by EPA under TSCA section 5(a)(3)(C).
------------------------------------------------------------------------
EPA case No. Chemical identity Website link
------------------------------------------------------------------------
J-21-0012....................... Yeast that has https://
been stably www.epa.gov/
modified for the system/files/
production of an documents/2021-07/
agricultural j-21-
product (generic). 0012_determinatio
n_non-
cbi_final_1.pdf.
J-21-0013....................... Yeast that has https://
been stably www.epa.gov/
modified for the system/files/
production of an documents/2021-07/
agricultural j-21-
product (generic). 0013_determinatio
n_non-
cbi_final.pdf.
P-21-0005....................... Carbonmonocyclic https://
alkene polymer www.epa.gov/
with alkyl system/files/
alkenoate, alkyl documents/2021-08/
alkenoate, alkyl p-21-
alkenoate and 0005_determinatio
polyalkyldiene n_non-
alkenoate. cbi_final_2.pdf.
(generic).
P-21-0078....................... Phenol, polymer https://
with alkyl- www.epa.gov/
(alkylalkylenyl)c system/files/
yclohexene, mixed documents/2021-07/
dialkylcyclohexad p-21-
ienes, mixed 0078_determinatio
alkyl- n_non-
(alkylalkylidene) cbi_final_0.pdf.
cyclohexenes and
3,7,7-
trimethylbicyclo[
4.1.0]hept-3-ene
(generic).
P-21-0095....................... Alkene Homopolymer https://
Hydrogenated www.epa.gov/
(generic). system/files/
documents/2021-07/
p-21-
0095_determinatio
n_non-
cbi_final_0.pdf.
P-21-0039, P-21-0040, P-21-0041. (P-21-0039) https://
1,2,4,5- www.epa.gov/
Benzenetetracarbo system/files/
xamide, documents/2021-07/
N1,N2,N4,N5- p-21-0039-
tetrahexyl-; 0041_determinatio
CASRN: 1142038-73- n_non-
0, (P-21-0040) cbi_final.pdf.
1,2,4,5-
Benzenetetracarbo
xamide,
N1,N2,N4,N5-
tetraoctyl-;
CASRN: 1416081-40-
7, (P-21-0041)
1,2,4,5-
Benzenetetracarbo
xamide,
N1,N2,N4,N5-
tetradodecyl-;
CASRN: 911127-84-
9.
P-21-0103....................... Urea, N-[3-[[(4- https://
methylphenyl)sulf www.epa.gov/
onyl]oxy]phenyl]- system/files/
N'-phenyl- documents/2021-07/
include; CASRN p-21-
2102522-55-2. 0103_determinatio
n_non-
cbi_final.pdf.
------------------------------------------------------------------------
Authority: 15 U.S.C. 2601 et seq.
Dated: August 10, 2021.
Madison Le,
Director, New Chemical Division, Office of Pollution Prevention and
Toxics.
[FR Doc. 2021-17661 Filed 8-17-21; 8:45 am]
BILLING CODE 6560-50-P
